Different plasma ghrelin levels after laparoscopic gastric bypass and adjustable gastric banding in morbid obese subjects

Frida Leonetti, Gianfranco Silecchia, Gianluca Iacobellis, Maria Cristina Ribaudo, Alessandra Zappaterreno, Claudio Tiberti, Concetta Valeria Iannucci, Nicola Perrotta, Vincenzo Bacci, Maria Sole Basso, Nicola Basso, Umberto Di Mario

Research output: Contribution to journalArticle

142 Citations (Scopus)

Abstract

Gastric bypass has been reported to be associated with markedly suppressed plasma ghrelin levels, suggesting that it is one of the possible weight-reducing factors related to this procedure. The aim of this study was the evaluation of plasma ghrelin levels in patients who had undergone laparoscopic Roux-en-Y gastric bypass (LRYGBP) and laparoscopic adjustable silicone gastric banding (LASGB). Normoweight, obese subjects and patients who had undergone total gastrectomy were used as controls. In this cross-sectional study, we selected 10 subjects who underwent LASGB, 11 subjects with LRYGBP, 10 obese subjects, eight patients with total gastrectomy, and eight normoweight subjects. Plasma ghrelin, insulin, and glucose profiles were determined before and after breakfast and lunch. Obese subjects showed a ghrelin plasma level significantly lower than normoweight subjects (407.3 ± 21.6 vs. 813 ± 72.4 pg/ml, P < 0.01). Patients with LRYGBP showed baseline ghrelin levels lower than LASGB (213.5 ± 73.9 vs. 314.2 ± 84.3 pg/ml, P = 0.04). Both groups of patients who underwent bariatric surgical procedures also had ghrelin lower than normoweight and obese subjects (P < 0.01 and P < 0.05, respectively). Patients with total gastrectomy showed plasmatic ghrelin levels extremely lower than those in all other groups (32.6 ± 18.7 pg/ml, P < 0.001 for all). The ghrelin profile in both groups of subjects who underwent LRYGBP and LASGB did not show any meal-related changes as observed in obese and normoweight control groups. Significant difference in plasma ghrelin levels between LRYGBP and LASGB was found, suggesting that both procedures could induce weight loss by different mechanisms in which ghrelin could be involved.

Original languageEnglish
Pages (from-to)4227-4231
Number of pages5
JournalJournal of Clinical Endocrinology and Metabolism
Volume88
Issue number9
DOIs
StatePublished - Sep 1 2003
Externally publishedYes

Fingerprint

Ghrelin
Gastric Bypass
Stomach
Plasmas
Silicones
Gastrectomy
Lunch
Bariatric Surgery
Breakfast
Meals
Weight Loss
Cross-Sectional Studies
Insulin
Weights and Measures
Glucose
Control Groups

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Different plasma ghrelin levels after laparoscopic gastric bypass and adjustable gastric banding in morbid obese subjects. / Leonetti, Frida; Silecchia, Gianfranco; Iacobellis, Gianluca; Ribaudo, Maria Cristina; Zappaterreno, Alessandra; Tiberti, Claudio; Iannucci, Concetta Valeria; Perrotta, Nicola; Bacci, Vincenzo; Basso, Maria Sole; Basso, Nicola; Di Mario, Umberto.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 88, No. 9, 01.09.2003, p. 4227-4231.

Research output: Contribution to journalArticle

Leonetti, F, Silecchia, G, Iacobellis, G, Ribaudo, MC, Zappaterreno, A, Tiberti, C, Iannucci, CV, Perrotta, N, Bacci, V, Basso, MS, Basso, N & Di Mario, U 2003, 'Different plasma ghrelin levels after laparoscopic gastric bypass and adjustable gastric banding in morbid obese subjects', Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 9, pp. 4227-4231. https://doi.org/10.1210/jc.2003-030133
Leonetti, Frida ; Silecchia, Gianfranco ; Iacobellis, Gianluca ; Ribaudo, Maria Cristina ; Zappaterreno, Alessandra ; Tiberti, Claudio ; Iannucci, Concetta Valeria ; Perrotta, Nicola ; Bacci, Vincenzo ; Basso, Maria Sole ; Basso, Nicola ; Di Mario, Umberto. / Different plasma ghrelin levels after laparoscopic gastric bypass and adjustable gastric banding in morbid obese subjects. In: Journal of Clinical Endocrinology and Metabolism. 2003 ; Vol. 88, No. 9. pp. 4227-4231.
@article{58c22806183b4d738f1412ce527263cd,
title = "Different plasma ghrelin levels after laparoscopic gastric bypass and adjustable gastric banding in morbid obese subjects",
abstract = "Gastric bypass has been reported to be associated with markedly suppressed plasma ghrelin levels, suggesting that it is one of the possible weight-reducing factors related to this procedure. The aim of this study was the evaluation of plasma ghrelin levels in patients who had undergone laparoscopic Roux-en-Y gastric bypass (LRYGBP) and laparoscopic adjustable silicone gastric banding (LASGB). Normoweight, obese subjects and patients who had undergone total gastrectomy were used as controls. In this cross-sectional study, we selected 10 subjects who underwent LASGB, 11 subjects with LRYGBP, 10 obese subjects, eight patients with total gastrectomy, and eight normoweight subjects. Plasma ghrelin, insulin, and glucose profiles were determined before and after breakfast and lunch. Obese subjects showed a ghrelin plasma level significantly lower than normoweight subjects (407.3 ± 21.6 vs. 813 ± 72.4 pg/ml, P < 0.01). Patients with LRYGBP showed baseline ghrelin levels lower than LASGB (213.5 ± 73.9 vs. 314.2 ± 84.3 pg/ml, P = 0.04). Both groups of patients who underwent bariatric surgical procedures also had ghrelin lower than normoweight and obese subjects (P < 0.01 and P < 0.05, respectively). Patients with total gastrectomy showed plasmatic ghrelin levels extremely lower than those in all other groups (32.6 ± 18.7 pg/ml, P < 0.001 for all). The ghrelin profile in both groups of subjects who underwent LRYGBP and LASGB did not show any meal-related changes as observed in obese and normoweight control groups. Significant difference in plasma ghrelin levels between LRYGBP and LASGB was found, suggesting that both procedures could induce weight loss by different mechanisms in which ghrelin could be involved.",
author = "Frida Leonetti and Gianfranco Silecchia and Gianluca Iacobellis and Ribaudo, {Maria Cristina} and Alessandra Zappaterreno and Claudio Tiberti and Iannucci, {Concetta Valeria} and Nicola Perrotta and Vincenzo Bacci and Basso, {Maria Sole} and Nicola Basso and {Di Mario}, Umberto",
year = "2003",
month = "9",
day = "1",
doi = "10.1210/jc.2003-030133",
language = "English",
volume = "88",
pages = "4227--4231",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "9",

}

TY - JOUR

T1 - Different plasma ghrelin levels after laparoscopic gastric bypass and adjustable gastric banding in morbid obese subjects

AU - Leonetti, Frida

AU - Silecchia, Gianfranco

AU - Iacobellis, Gianluca

AU - Ribaudo, Maria Cristina

AU - Zappaterreno, Alessandra

AU - Tiberti, Claudio

AU - Iannucci, Concetta Valeria

AU - Perrotta, Nicola

AU - Bacci, Vincenzo

AU - Basso, Maria Sole

AU - Basso, Nicola

AU - Di Mario, Umberto

PY - 2003/9/1

Y1 - 2003/9/1

N2 - Gastric bypass has been reported to be associated with markedly suppressed plasma ghrelin levels, suggesting that it is one of the possible weight-reducing factors related to this procedure. The aim of this study was the evaluation of plasma ghrelin levels in patients who had undergone laparoscopic Roux-en-Y gastric bypass (LRYGBP) and laparoscopic adjustable silicone gastric banding (LASGB). Normoweight, obese subjects and patients who had undergone total gastrectomy were used as controls. In this cross-sectional study, we selected 10 subjects who underwent LASGB, 11 subjects with LRYGBP, 10 obese subjects, eight patients with total gastrectomy, and eight normoweight subjects. Plasma ghrelin, insulin, and glucose profiles were determined before and after breakfast and lunch. Obese subjects showed a ghrelin plasma level significantly lower than normoweight subjects (407.3 ± 21.6 vs. 813 ± 72.4 pg/ml, P < 0.01). Patients with LRYGBP showed baseline ghrelin levels lower than LASGB (213.5 ± 73.9 vs. 314.2 ± 84.3 pg/ml, P = 0.04). Both groups of patients who underwent bariatric surgical procedures also had ghrelin lower than normoweight and obese subjects (P < 0.01 and P < 0.05, respectively). Patients with total gastrectomy showed plasmatic ghrelin levels extremely lower than those in all other groups (32.6 ± 18.7 pg/ml, P < 0.001 for all). The ghrelin profile in both groups of subjects who underwent LRYGBP and LASGB did not show any meal-related changes as observed in obese and normoweight control groups. Significant difference in plasma ghrelin levels between LRYGBP and LASGB was found, suggesting that both procedures could induce weight loss by different mechanisms in which ghrelin could be involved.

AB - Gastric bypass has been reported to be associated with markedly suppressed plasma ghrelin levels, suggesting that it is one of the possible weight-reducing factors related to this procedure. The aim of this study was the evaluation of plasma ghrelin levels in patients who had undergone laparoscopic Roux-en-Y gastric bypass (LRYGBP) and laparoscopic adjustable silicone gastric banding (LASGB). Normoweight, obese subjects and patients who had undergone total gastrectomy were used as controls. In this cross-sectional study, we selected 10 subjects who underwent LASGB, 11 subjects with LRYGBP, 10 obese subjects, eight patients with total gastrectomy, and eight normoweight subjects. Plasma ghrelin, insulin, and glucose profiles were determined before and after breakfast and lunch. Obese subjects showed a ghrelin plasma level significantly lower than normoweight subjects (407.3 ± 21.6 vs. 813 ± 72.4 pg/ml, P < 0.01). Patients with LRYGBP showed baseline ghrelin levels lower than LASGB (213.5 ± 73.9 vs. 314.2 ± 84.3 pg/ml, P = 0.04). Both groups of patients who underwent bariatric surgical procedures also had ghrelin lower than normoweight and obese subjects (P < 0.01 and P < 0.05, respectively). Patients with total gastrectomy showed plasmatic ghrelin levels extremely lower than those in all other groups (32.6 ± 18.7 pg/ml, P < 0.001 for all). The ghrelin profile in both groups of subjects who underwent LRYGBP and LASGB did not show any meal-related changes as observed in obese and normoweight control groups. Significant difference in plasma ghrelin levels between LRYGBP and LASGB was found, suggesting that both procedures could induce weight loss by different mechanisms in which ghrelin could be involved.

UR - http://www.scopus.com/inward/record.url?scp=0141676021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141676021&partnerID=8YFLogxK

U2 - 10.1210/jc.2003-030133

DO - 10.1210/jc.2003-030133

M3 - Article

C2 - 12970291

AN - SCOPUS:0141676021

VL - 88

SP - 4227

EP - 4231

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 9

ER -